Ball Corp has a consensus price target of $66.22 based on the ratings of 19 analysts. The high is $82 issued by RBC Capital on April 29, 2024. The low is $56 issued by UBS on July 17, 2024. The 3 most-recent analyst ratings were released by UBS, Wells Fargo, and Citigroup on July 17, 2024, July 17, 2024, and July 8, 2024, respectively. With an average price target of $61 between UBS, Wells Fargo, and Citigroup, there's an implied -3.16% downside for Ball Corp from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
07/17/2024 | Buy Now | -11.1% | UBS | Cleveland Rueckert | $57 → $56 | Maintains | Sell | Get Alert |
07/17/2024 | Buy Now | -3.16% | Wells Fargo | Gabe Hajde | $64 → $61 | Maintains | Equal-Weight | Get Alert |
07/08/2024 | Buy Now | 4.78% | Citigroup | Anthony Pettinari | $73 → $66 | Maintains | Neutral | Get Alert |
06/25/2024 | Buy Now | 20.65% | Truist Securities | Michael Roxland | $67 → $76 | Upgrade | Hold → Buy | Get Alert |
06/20/2024 | Buy Now | 1.6% | Wells Fargo | Gabe Hajde | $69 → $64 | Maintains | Equal-Weight | Get Alert |
05/06/2024 | Buy Now | 14.3% | Barclays | Michael Leithead | $71 → $72 | Maintains | Equal-Weight | Get Alert |
05/01/2024 | Buy Now | 11.13% | JP Morgan | Jeffrey Zekauskas | $59 → $70 | Maintains | Neutral | Get Alert |
04/29/2024 | Buy Now | 9.54% | Wells Fargo | Gabe Hajde | $65 → $69 | Maintains | Equal-Weight | Get Alert |
04/29/2024 | Buy Now | 6.37% | Truist Securities | Michael Roxland | $60 → $67 | Maintains | Hold | Get Alert |
04/29/2024 | Buy Now | 30.18% | RBC Capital | Arun Viswanathan | $74 → $82 | Maintains | Outperform | Get Alert |
04/29/2024 | Buy Now | 9.54% | Mizuho | John Roberts | $63 → $69 | Maintains | Neutral | Get Alert |
04/29/2024 | Buy Now | 11.13% | Baird | Ghansham Panjabi | $62 → $70 | Maintains | Neutral | Get Alert |
04/12/2024 | Buy Now | -4.75% | Truist Securities | Michael Roxland | $60 → $60 | Reiterates | Hold → Hold | Get Alert |
04/04/2024 | Buy Now | 12.72% | Barclays | Michael Leithead | $66 → $71 | Downgrade | Overweight → Equal-Weight | Get Alert |
03/27/2024 | Buy Now | 11.13% | Citigroup | Anthony Pettinari | → $70 | Reinstates | Neutral → Neutral | Get Alert |
03/22/2024 | Buy Now | 23.83% | Jefferies | Philip Ng | $69 → $78 | Maintains | Buy | Get Alert |
03/18/2024 | Buy Now | -1.57% | Wells Fargo | Gabe Hajde | $52 → $62 | Maintains | Equal-Weight | Get Alert |
03/18/2024 | Buy Now | 7.95% | Morgan Stanley | Angel Castillo | → $68 | Initiates | → Equal-Weight | Get Alert |
03/01/2024 | Buy Now | — | Wolfe Research | Chris Parkinson | — | Initiates | → Peer Perform | Get Alert |
02/20/2024 | Buy Now | 0.02% | Mizuho | John Roberts | $1 → $63 | Maintains | Neutral | Get Alert |
02/20/2024 | Buy Now | 17.48% | RBC Capital | Arun Viswanathan | $61 → $74 | Upgrade | Sector Perform → Outperform | Get Alert |
02/02/2024 | Buy Now | -3.16% | RBC Capital | Arun Viswanathan | $51 → $61 | Maintains | Sector Perform | Get Alert |
02/02/2024 | Buy Now | 4.78% | Barclays | Michael Leithead | $63 → $66 | Maintains | Overweight | Get Alert |
01/16/2024 | Buy Now | -12.68% | UBS | Cleveland Rueckert | → $55 | Initiates | → Sell | Get Alert |
01/04/2024 | Buy Now | -4.75% | Truist Securities | Michael Roxland | $54 → $60 | Maintains | Hold | Get Alert |
01/02/2024 | Buy Now | -6.33% | B of A Securities | George Staphos | $61 → $59 | Downgrade | Neutral → Underperform | Get Alert |
12/28/2023 | Buy Now | -1.57% | Mizuho | John Roberts | $60 → $62 | Maintains | Neutral | Get Alert |
11/06/2023 | Buy Now | -4.75% | Barclays | Michael Leithead | $59 → $60 | Maintains | Overweight | Get Alert |
10/19/2023 | Buy Now | -26.97% | Wells Fargo | Gabe Hajde | $55 → $46 | Maintains | Equal-Weight | Get Alert |
10/18/2023 | Buy Now | 0.02% | Jefferies | Philip Ng | $64 → $63 | Maintains | Buy | Get Alert |
10/11/2023 | Buy Now | -6.33% | Barclays | Michael Leithead | $61 → $59 | Upgrade | Equal-Weight → Overweight | Get Alert |
09/29/2023 | Buy Now | 1.6% | Jefferies | Philip Ng | $63 → $64 | Upgrade | Hold → Buy | Get Alert |
09/13/2023 | Buy Now | -7.92% | Credit Suisse | Curt Woodworth | $65 → $58 | Downgrade | Outperform → Neutral | Get Alert |
08/10/2023 | Buy Now | -11.1% | JP Morgan | Jeffrey Zekauskas | $57 → $56 | Maintains | Neutral | Get Alert |
08/04/2023 | Buy Now | 0.02% | Citigroup | Anthony Pettinari | $60 → $63 | Maintains | Neutral | Get Alert |
07/11/2023 | Buy Now | -4.75% | Citigroup | Anthony Pettinari | $61 → $60 | Maintains | Neutral | Get Alert |
06/23/2023 | Buy Now | -7.92% | RBC Capital | Arun Viswanathan | $58 → $58 | Reiterates | Sector Perform → Sector Perform | Get Alert |
06/20/2023 | Buy Now | -12.68% | Wells Fargo | Gabe Hajde | → $55 | Upgrade | Underweight → Equal-Weight | Get Alert |
06/07/2023 | Buy Now | -9.51% | JP Morgan | Jeffrey Zekauskas | $61 → $57 | Maintains | Neutral | Get Alert |
05/08/2023 | Buy Now | -3.16% | Citigroup | Anthony Pettinari | $60 → $61 | Maintains | Neutral | Get Alert |
05/08/2023 | Buy Now | -7.92% | RBC Capital | Arun Viswanathan | $56 → $58 | Maintains | Sector Perform | Get Alert |
05/05/2023 | Buy Now | -17.45% | Wells Fargo | Gabe Hajde | $51 → $52 | Maintains | Underweight | Get Alert |
04/18/2023 | Buy Now | -6.33% | Mizuho | Christopher Parkinson | $58 → $59 | Maintains | Neutral | Get Alert |
04/12/2023 | Buy Now | -7.92% | Truist Securities | Michael Roxland | → $58 | Reiterates | → Hold | Get Alert |
02/07/2023 | Buy Now | -3.16% | JP Morgan | Jeffrey Zekauskas | $55 → $61 | Maintains | Neutral | Get Alert |
02/06/2023 | Buy Now | 0.02% | Citigroup | Anthony Pettinari | $54 → $63 | Maintains | Neutral | Get Alert |
02/03/2023 | Buy Now | -19.03% | Wells Fargo | Gabe Hajde | $46 → $51 | Maintains | Underweight | Get Alert |
02/03/2023 | Buy Now | -7.92% | Mizuho | Christopher Parkinson | $53 → $58 | Maintains | Neutral | Get Alert |
01/12/2023 | Buy Now | -15.86% | Mizuho | Christopher Parkinson | $51 → $53 | Maintains | Neutral | Get Alert |
12/15/2022 | Buy Now | -7.92% | UBS | Cleveland Rueckert | $64 → $58 | Maintains | Neutral | Get Alert |
11/10/2022 | Buy Now | -3.16% | BMO Capital | Mark Wilde | $73 → $61 | Maintains | Outperform | Get Alert |
11/08/2022 | Buy Now | -12.68% | Barclays | Michael Leithead | $50 → $55 | Maintains | Equal-Weight | Get Alert |
11/04/2022 | Buy Now | -19.03% | Mizuho | Christopher Parkinson | $60 → $51 | Maintains | Neutral | Get Alert |
11/04/2022 | Buy Now | -19.03% | RBC Capital | Arun Viswanathan | $53 → $51 | Maintains | Sector Perform | Get Alert |
10/24/2022 | Buy Now | -4.75% | Mizuho | Christopher Parkinson | $74 → $60 | Maintains | Neutral | Get Alert |
09/26/2022 | Buy Now | -12.68% | Truist Securities | Michael Roxland | $61 → $55 | Maintains | Hold | Get Alert |
09/26/2022 | Buy Now | -14.27% | Citigroup | Anthony Pettinari | $64 → $54 | Maintains | Neutral | Get Alert |
09/23/2022 | Buy Now | -26.97% | Wells Fargo | Gabe Hajde | $53 → $46 | Maintains | Underweight | Get Alert |
09/23/2022 | Buy Now | 3.19% | Credit Suisse | Curt Woodworth | $77 → $65 | Maintains | Outperform | Get Alert |
09/15/2022 | Buy Now | 1.6% | UBS | Cleve Rueckert | → $64 | Initiates | → Neutral | Get Alert |
09/07/2022 | Buy Now | -12.68% | Morgan Stanley | Angel Castillo | $56 → $55 | Maintains | Equal-Weight | Get Alert |
08/08/2022 | Buy Now | -12.68% | Barclays | Michael Leithead | $80 → $55 | Maintains | Equal-Weight | Get Alert |
08/08/2022 | Buy Now | -7.92% | JP Morgan | Jeffrey Zekauskas | $80 → $58 | Downgrade | Overweight → Neutral | Get Alert |
08/05/2022 | Buy Now | -3.16% | Truist Securities | Michael Roxland | $93 → $61 | Maintains | Hold | Get Alert |
08/05/2022 | Buy Now | 3.19% | Deutsche Bank | Kyle White | $81 → $65 | Downgrade | Buy → Hold | Get Alert |
08/05/2022 | Buy Now | -7.92% | Atlantic Equities | Colin Isaac | $80 → $58 | Downgrade | Overweight → Neutral | Get Alert |
08/05/2022 | Buy Now | 1.6% | RBC Capital | Arun Viswanathan | $74 → $64 | Maintains | Sector Perform | Get Alert |
08/04/2022 | Buy Now | 47.64% | Truist Securities | Michael Roxland | → $93 | Downgrade | Buy → Hold | Get Alert |
06/09/2022 | Buy Now | 3.19% | Wells Fargo | Gabe Hajde | $74 → $65 | Downgrade | Equal-Weight → Underweight | Get Alert |
05/17/2022 | Buy Now | 47.64% | Truist Securities | Michael Roxland | → $93 | Upgrade | Hold → Buy | Get Alert |
05/11/2022 | Buy Now | 17.48% | Wells Fargo | Gabe Hajde | $92 → $74 | Maintains | Equal-Weight | Get Alert |
The latest price target for Ball (NYSE:BALL) was reported by UBS on July 17, 2024. The analyst firm set a price target for $56.00 expecting BALL to fall to within 12 months (a possible -11.10% downside). 35 analyst firms have reported ratings in the last year.
The latest analyst rating for Ball (NYSE:BALL) was provided by UBS, and Ball maintained their sell rating.
The last upgrade for Ball Corp happened on June 25, 2024 when Truist Securities raised their price target to $76. Truist Securities previously had a hold for Ball Corp.
The last downgrade for Ball Corp happened on April 4, 2024 when Barclays changed their price target from $66 to $71 for Ball Corp.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Ball, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Ball was filed on July 17, 2024 so you should expect the next rating to be made available sometime around July 17, 2025.
While ratings are subjective and will change, the latest Ball (BALL) rating was a maintained with a price target of $57.00 to $56.00. The current price Ball (BALL) is trading at is $62.99, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.